Pfizer Exubera Launch May Demonstrate Impact Of Revised DTC Ad Policy
Executive Summary
Launch of Pfizer/Sanofi-Aventis' inhaled insulin Exubera could demonstrate the impact of Pfizer's new direct-to-consumer advertising guidelines
You may also be interested in...
Pfizer Holding Its Breath On Exubera DTC Advertising To Focus On Education
Pfizer will begin direct-to-consumer advertising for its inhaled insulin therapy Exubera approximately one year after its approval, the company said at a June 10 briefing in Washington, D.C
Pfizer Holding Its Breath On Exubera DTC Advertising To Focus On Education
Pfizer will begin direct-to-consumer advertising for its inhaled insulin therapy Exubera approximately one year after its approval, the company said at a June 10 briefing in Washington, D.C
Pfizer DTC Guidelines Include New Brief Summary Format
Pfizer intends to use a new "brief summary" format in its direct-to-consumer advertisements, the company said in an Aug. 11 announcement of changes to its DTC policy